String of publications describes attempts — mostly unsuccessful — to use proposed CRISPR rival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
199,00 € per year
only 3,90 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
29 November 2016
The story has been updated to include details of the most recent Nature Biotechnology report and the journal’s ‘expression of concern’, as well as fresh comments from Han Chunyu and Nature Biotechnology, which followed those publications.
References
Gao, F., Shen, X. Z., Jiang, F., Wu, Y. & Han, C. Nature Biotech. 34, 768–773 (2016).
Burgess, S. et al. Protein Cell http://dx.doi.org/10.1007/s13238-016-0343-9 (2016).
Qi, J. et al. Cell Res. http://dx.doi.org/10.1038/cr.2016.134 (2016).
Lee, S-H. et al. Nature Biotechnol. http://dx.doi.org/10.1038/nbt.3753 (2016).
Related links
Related links
Related links in Nature Research
Beyond CRISPR: A guide to the many other ways to edit a genome 2016-Aug-08
CRISPR, the disruptor 2015-Jun-03
Related external links
Rights and permissions
About this article
Cite this article
Cyranoski, D. Updated: NgAgo gene-editing controversy escalates in peer-reviewed papers. Nature 540, 20–21 (2016). https://doi.org/10.1038/nature.2016.21023
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature.2016.21023